CoDa Therapeutics' Series A - II Round

CoDa Therapeutics raised a round of funding on February 21, 2007.

CoDa Therapeutics is a clinical stage biotechnology company focused on developing targeted therapies that address major unmet medical needs in inflammation, wound-healing and tissue repair. The compan…

Articles about CoDa Therapeutics' Series A - II Round: